Table 4 Univariate and multivariate logistic regression analysis of LVSD

Age

1.02 (1.00-1.03)

1.01 (1.00-1.03)

Female (vs. Male)

1.49 (0.84–2.65)

STEMI (vs. NSTEMI)

1.87 (1.15–3.04)

1.76 (1.03-3.00)

COVID-19 infection

1.68 (1.11–2.56)

1.73 (1.11–2.69)

DM

1.38 (0.90–2.10)

Hypertension

0.83 (0.56–1.22)

Cerebrovascular diseases

1.69 (0.94–3.04)

1.52 (0.80–2.88)

Chronic lung diseases

1.35 (0.68–2.69)

Smoking history

1.01 (0.67–1.53)

Symptom-to-FMC

1.02 (1.00-1.05)

1.03 (1.00-1.05)

Killip class 3–4 at admission (vs. Killip class 1–2)

2.16 (0.99–4.75)

1.34 (0.55–3.22)

Antiplatelet therapies

1.44 (0.54–3.82)

Multivessel CAD

1.21 (0.81–1.81)

PCI

0.68 (0.41–1.12)

Peak CK-MB

1.003 (1.002–1.005)

1.003 (1.002–1.005)

Creatinine

1.00 (1.00-1.01)

1.004 (1.000-1.009)

D-Dimer

0.99 (0.96–1.01)